Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation

2000/10/01 by Marjan Jahangiri, Jacqueline Kreutzer, David Zurakowski +2 · 9 citations
Engineering · Medicine · #Antithrombin #Blood Coagulation and Thrombosis Mechanisms #Cardiology #Coagulation #Congenital Heart Disease Studies #Fontan procedure #Heart disease #Heparin #Inferior vena cava #Internal medicine #Mechanical Circulatory Support Devices #Medicine #Protein C #Surgery

paper · pdf · doi:10.1067/mtc.2000.108903

openalex publication_date 2000/10/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/27

Cited by

• Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity. [europepmc]
• Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology. [europepmc]
• The use of anticoagulation in pediatric cardiac disease. [europepmc]
• Acute Ischemic Pediatric Stroke Management: An Extended Window for Mechanical Thrombectomy? [europepmc]
• Physiological Fontan Procedure. [europepmc]
• Venous thromboembolism in chronic pediatric heart disease is associated with substantial health care burden and expenditures. [europepmc]
• Increased Risk for Thromboembolism After Fontan Surgery: Considerations for Thromboprophylaxis. [europepmc]
• Coagulation Profile in Neonates with Congenital Heart Disease: A Pilot Study. [europepmc]
• Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy. [europepmc]